Chambers Review
Provided by Chambers
Email address
[email protected]Contact number
+33 1 53 57 65 19Share profile
Band 1
Provided by Philippe Dubois
Philippe Dubois has considerable experience in restructuring & insolvency. He advises banking and financial institutions as well as large French and foreign industrial groups in a wide range of economic sectors. His practice focuses on restructuring, litigation and arbitration in diverse areas such as shareholder disputes, indemnification agreements and liabilities.
He joined De Pardieu Brocas Maffei in 2008 as a Partner, after working at Jeantet (1984-2005) and Sonier Poulain (2005-07). He manages the firm's Restructuring and Insolvency team.
Member of the Paris Bar since 1994.
Doctor at law, he teaches business law at the University of Paris X.
Provided by Chambers
Provided by Chambers
2 items provided by De Pardieu Brocas Maffei
De Pardieu advises Biosynex’s banks on the restructuring of its financial debt
De Pardieu has advised the Banks of the French laboratory Biosynex, specializing in rapid tests, biotherapy monitoring and molecular biology, on the negotiation and conclusion of an agreement on the terms of its financial debt restructuring.
De Pardieu advises Biosynex’s banks on the restructuring of its financial debt
De Pardieu has advised the Banks of the French laboratory Biosynex, specializing in rapid tests, biotherapy monitoring and molecular biology, on the negotiation and conclusion of an agreement on the terms of its financial debt restructuring.
De Pardieu advises Biosynex’s banks on the restructuring of its financial debt
De Pardieu has advised the Banks of the French laboratory Biosynex, specializing in rapid tests, biotherapy monitoring and molecular biology, on the negotiation and conclusion of an agreement on the terms of its financial debt restructuring.
De Pardieu advises Biosynex’s banks on the restructuring of its financial debt
De Pardieu has advised the Banks of the French laboratory Biosynex, specializing in rapid tests, biotherapy monitoring and molecular biology, on the negotiation and conclusion of an agreement on the terms of its financial debt restructuring.